Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02522637Not ApplicableCompleted

Exercise Training in Severe COPD

Role: collaborator

NCT03322787Not ApplicableCompleted

Effect of Exercise Training Under HFO Device on Endurance Tolerance in Patients With COPD and CRF: a Randomized Controlled Study.

Role: collaborator

NCT01718067Not ApplicableUnknown

Efficacy of Vakum Technology in Patients With Chronic Hypersecretion

Role: lead

NCT01305668Completed

Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema

Role: lead

NCT00992498Completed

Rehabilitation in Chronic Obstructive Pulmonary Disease Outpatients

Role: lead

NCT01510275Not ApplicableCompleted

Combined Use of Respiratory Devices After Thoracic Surgery

Role: lead

NCT00700388Phase 4Completed

Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion

Role: lead

NCT00825032Not ApplicableCompleted

Efficacy of Arm Training in COPD Patients

Role: lead

NCT01303913Completed

Predicting Oxygen Desaturation in Chronic Obstructive Pulmonary Disease (COPD) Patients

Role: lead

All 9 trials loaded